Please ensure Javascript is enabled for purposes of website accessibility
top of page
N=1 Collaborative

Employers Don't Want to Pay for Life-Saving Cures for Rare Diseases

Gerry Smith (Bloomberg)

September 5, 2024


As a wave of gene therapies with multimillion-dollar price tags hit the market, many employers are dropping coverage and leaving families in a bind.


For Amanda Reed, the blows came one after another, a gut-punch introduction to motherhood.


Newborn screening this spring revealed her twin boys had a rare inherited condition called spinal muscular atrophy, or SMA. The severe form can be fatal by the age of two if left untreated.


The good news: a gene therapy called Zolgensma could potentially cure them. Then the bad: It would cost $4.2 million to treat both boys. Reed’s employer, the nonprofit hospital owner Mosaic Life Care in St. Joseph, Missouri, had recently decided to stop paying for gene therapies, the world’s most expensive treatments.



ree
Image Credit: Amanda Reed


1 Comment


Azmi
Azmi
Sep 30

My husband was diagnosed with Creutzfeldt-Jakob Disease (CJD) four years ago. For over two years, we relied on prescription medications and therapies, but unfortunately, his symptoms continued to worsen. His memory, coordination, and overall strength declined, and everyday life became increasingly difficult.Last year, out of desperation and hope, we decided to try an herbal treatment program from NaturePath Herbal Clinic. Honestly, we were skeptical at first, but within a few months of starting the treatment, we began to notice real changes. His alertness improved, his movements became steadier, and he regained a surprising amount of energy and clarity.Incredibly, he also regained much of his independence and confidence. It’s been a life-changing experience he feels more like himself again, better than…

Like

Join Our Community List

Relationship Required
Area(s) of Interest Required

Thanks for submitting!

N=1 Collaborative

Contact Us

501c3 Nonprofit Organization

EIN: 88-2591503

©2024 by N=1 Collaborative

Crafted By: Finfrock Marketing

bottom of page